Quick Summary:
In the rapidly evolving world of dermatology, understanding industry trends and advancements is crucial. This cutting-edge report provides a deep dive into the global Hyperpigmentation Disorders Treatment market, expected to surge from its current estimate of US$5 billion to reach an impressive US$7.9 billion by 2030. This comprehensive analysis will help you stay ahead of the curve, with a particular focus on growth sectors including Topical Drugs and Laser Therapy.
Region-specific data from key players such as the United States and China provide a truly global perspective. We've meticulously dissected the market, isolating growth forecasts for each respective unique context. The identification of top competitors, their comparative market shares, and operational geographies shapes a well-rounded understanding of the competitive landscape. The inclusion of new developments, researched trends, and complimentary year-long updates enriches this essential reading. Equip your business with the insight needed to thrive in this blossoming industry.
Global Hyperpigmentation Disorders Treatment Market to Reach $7.9 Billion by 2030
The global market for Hyperpigmentation Disorders Treatment estimated at US$5 Billion in the year 2022, is projected to reach a revised size of US$7.9 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2022-2030. Topical Drugs, one of the segments analyzed in the report, is projected to record 6.6% CAGR and reach US$3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Laser Therapy segment is readjusted to a revised 6.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 5.5% CAGR
The Hyperpigmentation Disorders Treatment market in the U.S. is estimated at US$1.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 5.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.6% and 4.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.Select Competitors (Total 41 Featured) -
- Allergan PLC
- Bayer AG
- Epipharm AG
- Galderma SA
- Obagi Cosmeceuticals LLC (Obagi Medical)
- Pierre Fabre S.A
- RXi Pharmaceuticals Corporation
- SkinCeuticals
- Vivier Pharma, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Hyperpigmentation Disorders Treatment?
What is the growth rate of the Global Market for Hyperpigmentation Disorders Treatment?
What is the forecasted size of the Global Market for Hyperpigmentation Disorders Treatment?
Who are the key companies in the Global Market for Hyperpigmentation Disorders Treatment?
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 5 Billion |
| Forecasted Market Value ( USD | $ 7.9 Billion |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Allergan PLC
- Bayer AG
- Epipharm AG
- Galderma SA
- Obagi Cosmeceuticals LLC (Obagi Medical)
- Pierre Fabre S.A
- RXi Pharmaceuticals Corporation
- SkinCeuticals
- Vivier Pharma, Inc.
